About Imon Ghosh
Imon is an investment analyst and journalist with an enthusiasm for financial research and writing. She began her career at Kantar IMRB, a leading market research and consumer consulting organization.
Imon studied St. Xavier's University, where she majored in Economics and wrote her academic thesis on inflation and the stock market.
Recent Articles By Imon Ghosh
Down 20% YTD, is Now a Good Time to Buy StoneCo?
Leading Brazil-based fintech company StoneCo (STNE) has achieved a significant improvement in its client base since its IPO in 2018. However, the stock has declined nearly 25% in price over the past month. So, given that interest rate hikes and inflationary pressures continue to ravage the Brazilian economy, will the stock be able to recover anytime soon? Read on to learn our view.
Here's Why You Should Add Eastman Chemical Stock to Your Portfolio Now
Advanced materials and specialty chemicals company Eastman Chemical (EMN) has witnessed record sales growth across all segments, driven by growing end-market demand for specialty plastics. The company’s substantial investment in accelerating the transition to a circular economy has captured investor interest in the stock. Also, EMN’s reasonable valuation, despite the company’s solid growth prospects, we think makes it a solid bet now. Let’s discuss.
Should You Buy the Dip in PPG Industries?
Shares of paints and coatings manufacturer PPG Industries (PPG) have retreated nearly 10% in price over the past month as the company continues to grapple with heightened supply and COVID-related disruptions. But while accelerating investments to expand its production facilities could bode well for the company, given the concerns surrounding raw materials and logistics cost inflation and labor shortages, can its shares recover in the near term? Read more to learn our view.
Should You Buy the Breakout in Petrobras?
Brazil-based oil and gas conglomerate Petrobras (PBR) has been ramping up its production volumes and strategic investments to capitalize on the uptick in Brent prices and the prices of oil products in the domestic market. Consequently, the stock recently hit a new 52-week price high. So, does the stock have further upside to deliver? Read on to learn our view.
Should You Buy the Dip in Smartsheet?
The shares of enterprise platform Smartsheet (SMAR) tumbled in price recently despite the company booking a significant number of large deals in the third quarter. And although growing subscription revenue could boost its financials, SMAR’s growth path is still fraught with challenges. So, given its widening losses, can the stock recover from its recent price dip? Let’s find out.
Up 10% in the Past Month, is MetLife Still a Buy?
Leading life insurance provider MetLife’s (MET) shares have shot up 12.5% in price over the past month thanks to earnings and premium revenues growth across all its business segments in its last reported quarter. With increasing risk awareness spurring the demand for insurance plans, is the stock poised to rally further? Let’s discuss.
Should You Buy the Dip in Blackstone Stock?
Shares of the world’s largest asset management company, Blackstone (BX), have retreated 16.3% in price over the past month despite the company achieving record financial performance in the third quarter. Although its strategic acquisition and increasing investments in clean energy have attracted investors, given that the stock is currently trading at a stretched valuation, can it recover from its recent price dip? Let’s find out.
Is MicroStrategy a Good Stock to Own in 2022?
Business intelligence company MicroStrategy’s (MSTR) shares have tumbled in price recently because of growing pessimism surrounding the company’s expanding bitcoin holdings. With bitcoin plunging as a crypto retreat continues, MSTR’s growth prospects look gloomy. Also, given MSTR’s weak profitability, can the stock recover soon? Read ahead to learn more.
Is Philip Morris a Good Dividend Stock to Buy for 2022?
Tobacco maker Philip Morris International (PM) has effectively increased its dividend payouts over time. However, given the constraints in its IOQS device supply due to the global semiconductors shortage and its impact on the company’s market share and user growth, can the stock keep rallying? Let’s find out.